scispace - formally typeset
M

Mary E. Harper

Researcher at National Institutes of Health

Publications -  21
Citations -  4093

Mary E. Harper is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Virus & Gene. The author has an hindex of 17, co-authored 21 publications receiving 4074 citations. Previous affiliations of Mary E. Harper include North Shore-LIJ Health System.

Papers
More filters
Journal ArticleDOI

HTLV-III infection in brains of children and adults with AIDS encephalopathy

TL;DR: Brains from 15 individuals with AIDS and encephalopathy were examined by Southern analysis and in situ hybridization for the presence of human T-cell leukemia (lymphotropic) virus type III (HTLV-III), the virus believed to be the causative agent of AIDS.
Journal ArticleDOI

Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization

TL;DR: It is demonstrated that HTLV-III expression in lymph node and peripheral blood is very low in vivo and the lymph node hyperplasia observed in HT LV-III-associated lymphadenopathy is not directly due to proliferation of HTLV -III-infected lymphocytes.
Journal ArticleDOI

The trans-activator gene of HTLV-III is essential for virus replication

TL;DR: It is shown that derivatives of a biologically competent molecular clone of HTLV-III, in which the tat-Ill gene is deleted or the normal splicing abrogated, failed to produce or expressed unusually low levels of virus, respectively, when transfected into T-cell cultures.
Journal ArticleDOI

Multiple sclerosis and human T-cell lymphotropic retroviruses.

TL;DR: A combination of different types of data suggests that some multiple sclerosis patients respond immunologically to, and have cerebrospinal T cells containing, a retrovirus that is related to, but distinct from, the three types of human T-cell lymphotropic viruses.
Book ChapterDOI

Molecular Biology of Human T-Lymphotropic Retroviruses

TL;DR: HTLV-III frequently infects the brain of acquired immunodeficiency syndrome patients who suffer from central nervous system disorders and poses the problem of crossing the blood-brain barrier in therapy strategies to eradicate the virus, which provides a basis for new classification of retroviruses.